Canagliflozin and Metformin Extended-Release Tablets and Esketamine nasal
Determining the interaction of Canagliflozin and Metformin Extended-Release Tablets and Esketamine nasal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canagliflozin / metformin
Brand name: Invokamet, Invokamet XR
Synonyms: Canagliflozin and metformin, Canagliflozin and Metformin
Generic Name: esketamine
Brand name: Spravato
Synonyms: Esketamine (nasal), Esketamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canagliflozin and Metformin Extended-Release Tablets-Eslicarbazepine
- Canagliflozin and Metformin Extended-Release Tablets-Eslicarbazepine Acetate
- Canagliflozin and Metformin Extended-Release Tablets-Esmolol
- Canagliflozin and Metformin Extended-Release Tablets-Esmolol HCl
- Canagliflozin and Metformin Extended-Release Tablets-Esmolol Hydrochloride
- Canagliflozin and Metformin Extended-Release Tablets-Esmolol Injection
- Esketamine nasal-Canagliflozin and Metformin Tablets
- Esketamine nasal-Canakinumab
- Esketamine nasal-Canakinumab Subcutaneous
- Esketamine nasal-Canasa
- Esketamine nasal-Canasa Pac rectal
- Esketamine nasal-Canasa rectal